Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Stockholder-Equity" stands at -75.89 Billion United States Dollars as of 09/30/2025.
As of the end of Johnson & Johnson's third quarter, the item "Other Stockholder Equity" stands at -75.89 Billion USD. This represents a decrease of -0.23 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.268 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.268 Billion United States Dollars.
The 3 year change is -34.74 Billion United States Dollars.
The 5 year change is -37.35 Billion United States Dollars.
The 10 year change is -54.43 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Stockholder Equity | 905,699,262,464.00 |
![]() | AbbVie Inc - Other Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Stockholder Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Stockholder Equity | 280,205,508,085.11 |
![]() | Novartis AG - Other Stockholder Equity | 255,096,620,580.91 |